Allspring Global Investments Holdings LLC grew its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) by 0.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 166,645 shares of the medical instruments supplier's stock after purchasing an additional 1,560 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.43% of AngioDynamics worth $3,409,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in ANGO. Victory Capital Management Inc. lifted its stake in AngioDynamics by 3.4% during the second quarter. Victory Capital Management Inc. now owns 2,933,155 shares of the medical instruments supplier's stock valued at $56,757,000 after purchasing an additional 96,263 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of AngioDynamics by 1.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,750,872 shares of the medical instruments supplier's stock valued at $59,255,000 after acquiring an additional 46,173 shares during the last quarter. Polar Capital Holdings Plc boosted its stake in shares of AngioDynamics by 21.6% during the 1st quarter. Polar Capital Holdings Plc now owns 1,882,375 shares of the medical instruments supplier's stock worth $40,546,000 after acquiring an additional 334,649 shares in the last quarter. FMR LLC grew its holdings in shares of AngioDynamics by 7.7% in the 2nd quarter. FMR LLC now owns 1,813,546 shares of the medical instruments supplier's stock worth $35,093,000 after acquiring an additional 130,429 shares during the last quarter. Finally, Loomis Sayles & Co. L P raised its position in shares of AngioDynamics by 10.6% during the second quarter. Loomis Sayles & Co. L P now owns 1,400,992 shares of the medical instruments supplier's stock worth $27,109,000 after purchasing an additional 134,075 shares during the period. Institutional investors and hedge funds own 94.94% of the company's stock.

AngioDynamics Stock Performance

Shares of AngioDynamics stock opened at $13.83 on Wednesday. AngioDynamics, Inc. has a 12 month low of $11.71 and a 12 month high of $24.87. The company has a quick ratio of 1.30, a current ratio of 2.16 and a debt-to-equity ratio of 0.12. The stock has a market cap of $541.22 million, a PE ratio of -16.66 and a beta of 0.66. The business has a fifty day simple moving average of $13.38 and a 200-day simple moving average of $17.59.

Analyst Ratings Changes

AngioDynamics Company Profile

(Get Rating)

AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally.

See Also

• Get a free copy of the StockNews.com research report on AngioDynamics (ANGO)
• Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
• Can Alaska Air Continue Soaring Above The Airline Industry?
• Insulet Has Potential To Gain More Than Analysts Are Forecasting
• Cathie Wood Is Buying These Stocks, Should You?
• Tritium Is the Largest DC EV Charger Maker You've Never Heard Of

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.